Relationship between fibroblast growth factor 23 level and vitamin D status in chronic kidney disease: A cross-sectional study
Open Access
- 14 April 2024
- journal article
- research article
- Published by Institute of Nephrology of the National Academy of Medical Sciences in Ukrainian Journal of Nephrology and Dialysis
- No. 2(82),p. 43-51
Abstract
Complications stemming from chronic kidney disease (CKD) significantly contribute to increased morbidity and mortality rates. During the early stages of CKD, a delicate balance in homeostasis and mineral regulation is maintained largely due to fibroblast growth factor 23 (FGF-23). However, as kidney function declines, there is a detrimental effect on vitamin D synthesis. Understanding the dynamics of FGF-23 levels in relation to vitamin D status is crucial for assessing kidney function and its implications on hormonal regulation, calcium homeostasis, and cardiovascular health. Therefore, this study aimed to scrutinize and comprehend the correlation between FGF-23 levels and vitamin D status in patients afflicted with CKD. Methods. A cross-sectional study was undertaken at Dr. Wahidin Sudirohusodo Hospital in Makassar, South Sulawesi, Indonesia, involving 58 patients diagnosed with stage 3-5 non-dialysis CKD. Relationships between FGF-23 level with vitamin D level status and CKD stage were analyzed by chi-square and Kruskal-Wallis test. Results. The FGF-23 levels, with a median of 100 pg/mL as the designated cut-off, exhibit significance concerning the levels of vitamin D (p=0.003). The average values of FGF-23 in cases of deficiency and insufficiency are markedly elevated when compared to patients with sufficient vitamin D levels (p=0.016). The significance of FGF-23 levels becomes more prominent with advancing CKD stages (p=0.06). Conclusions. FGF-23 is a related marker with vitamin D deficiency in patients with CKD but is inconsistent in stage development and not an independent factor.Keywords
This publication has 51 references indexed in Scilit:
- Metabolic and Genetic Association of Vitamin D with Calcium Signaling and Insulin ResistanceIndian Journal of Clinical Biochemistry, 2022
- The effect of vitamin D supplementation on fibroblast growth factor‐23 in patients with chronic kidney disease: A systematic review and meta‐analysisPhytotherapy Research, 2021
- Vitamin D Supplementation for Patients with Chronic Kidney Disease: A Systematic Review and Meta-analyses of Trials Investigating the Response to Supplementation and an Overview of GuidelinesCalcified Tissue International, 2021
- Fibroblast growth factor 23 counters vitamin D metabolism and action in human mesenchymal stem cellsThe Journal of Steroid Biochemistry and Molecular Biology, 2020
- Calcium Disorders in End-Stage Renal Failure Including Those on Dialysis2020
- Brief Overview of Calcium, Vitamin D, Parathyroid Hormone Metabolism, and Calcium-Sensing Receptor Function2020
- Vitamin D Metabolism Revised: Fall of DogmasJournal of Bone and Mineral Research, 2019
- Physiological regulation of phosphate by vitamin D, parathyroid hormone (PTH) and phosphate (Pi)Pflügers Archiv - European Journal of Physiology, 2018
- The Effect of Vitamin D Supplementation on Bone Metabolic Markers in Chronic Kidney DiseaseJournal of Bone and Mineral Research, 2017
- Pleiotropic effects of vitamin D in chronic kidney diseaseClinica Chimica Acta, 2016